← FDA Drug Approvals (Drugs@FDA)

VIGABATRIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DEXCEL · Approved 2021-09-23

Drug application

FDA Application #

ANDA215109

Application type

Abbreviated New Drug Application (Generic)

Brand name

VIGABATRIN

Generic name

VIGABATRIN

Active ingredients

VIGABATRIN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

DEXCEL

Manufacturer

Edenbridge Pharmaceuticals LLC.

First approval

2021-09-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown